NASDAQ:ASPX (ASPX) (ASPX) Stock Price, News & Analysis → The Overlooked Retirement Asset You Probably Don’t Own (From Crypto 101 Media) (Ad) Free ASPX Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage Volume1.02 million shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get (ASPX) alerts: Email Address Ad Porter & CompanyObama’s Forever Term [exposed]America’s Last Election New documentary, America’s Last Election, reveals the true (and terrifying) story of how the D.C. establishment has engineered a brutal new crisis that could hand them permanent power. Power they will use to reshape America to their dark, dystopian vision.Start streaming it now at no cost here About (ASPX) Stock (NASDAQ:ASPX)Auspex Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of medicines for people with movement disorders and other rare diseases, including orphan diseases. Its pipeline includes product candidates to address unmet medical needs in hyperkinetic movement disorders, such as chorea (abnormal involuntary movements) associated with Huntington's disease, an orphan disease, tardive dyskinesia and Tourette syndrome in the pediatric population, which is an orphan disease, as well as other orphan indications. Its lead product candidate is SD-809, which is a small molecule inhibitor of vesicular monoamine transporter 2 (VMAT2). Its other programs include SD-560, SD-1077 and SD-254.Read More Ad Porter & CompanyObama’s Forever Term [exposed]America’s Last Election New documentary, America’s Last Election, reveals the true (and terrifying) story of how the D.C. establishment has engineered a brutal new crisis that could hand them permanent power. Power they will use to reshape America to their dark, dystopian vision.Start streaming it now at no cost here ASPX Stock News HeadlinesMay 18 at 12:23 AM | msn.comJeff Davis Police Jury releases names of candidates for parish administratorMay 17 at 7:22 PM | msn.comWFISD to sell large tract of landMay 17 at 9:21 AM | msn.comSan Bernardino County to host online tax sale auction for thousands of unpaid parcelsMay 16 at 8:24 PM | msn.comOregon warns consumers about raw milk as bird flu hits dairy cows nationwideMay 16 at 3:23 PM | msn.comRestaurant inspections: Live and dead roaches lead to Cathedral City eatery closureMay 15 at 7:38 PM | yahoo.comHere are Thurston County food safety scores for May 15May 15 at 7:38 PM | msn.comAztec Fluids & Machinery IPO share allotment to be finalised today: How to check status? A step-by-step guideMay 15 at 7:38 PM | msn.comPiotex Industries IPO allotment to be finalised today: Here's how to check allotment status as focus shifts to listingMay 14, 2024 | msn.comGrant Me Hope: Lucas hopes for a ‘active, patient’ familyMay 14, 2024 | msn.comExploring how intense ultrasound can release biological indicators of diseaseMay 14, 2024 | msn.comTBO Tek IPO allotment finalised: Here's a step-by-step guide to check statusMay 13, 2024 | yahoo.comCanadian wildfire smoke causes air quality alert in South DakotaMay 13, 2024 | msn.comUAE: Are you facing online bullying or privacy violation? Here's how to report cybercrimeMay 13, 2024 | msn.comPune varsity extends deadline for online applications till May 20May 11, 2024 | msn.comCivic calendar | Arcata’s Gateway code to be discussedMay 11, 2024 | msn.comAadhar Housing Finance IPO allotment to be out on May 13. Latest GMP, steps to check application statusMay 11, 2024 | msn.comTBO Tek IPO allotment to be finalised on May 13. Latest GMP, steps to check statusMay 10, 2024 | msn.comTBO Tek IPO allotment status: Check application status, latest GMP and listing dateMay 10, 2024 | msn.comOn the agenda: Tax exemption for downtown apartments returns to Salem City CouncilMay 10, 2024 | msn.comGovernor Moore Signs Legislation to Transform Maryland's Economic and Social LandscapeMay 10, 2024 | msn.comCommon drivers of high-performing public health programs revealedMay 10, 2024 | msn.comWinsol Engineers IPO Allotment: Check the Latest GMP, Subscription Status And Step-By-Step GuideMay 9, 2024 | msn.comClinical trial shows CRISPR gene editing has exciting potential to treat a rare form of blindnessMay 9, 2024 | msn.comState 21 improvements in Winnebago County will start a year sooner than first planned. Here's what to know.May 9, 2024 | msn.comUS Embassy Issues New Visa Processing Requirements | Check DirectiveSee More Headlines Receive ASPX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for (ASPX) and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/16/2015Today5/17/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorN/A Industry N/A Sub-IndustryN/A Current SymbolNASDAQ:ASPX CUSIPN/A CIK1454189 WebN/A Phone+1-858-5582400FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report ASPX Stock Analysis - Frequently Asked Questions How were (ASPX)'s earnings last quarter? (ASPX) (NASDAQ:ASPX) issued its earnings results on Monday, March, 16th. The biopharmaceutical company reported ($0.74) earnings per share for the quarter, missing the consensus estimate of ($0.59) by $0.15. What other stocks do shareholders of (ASPX) own? Based on aggregate information from My MarketBeat watchlists, some companies that other (ASPX) investors own include Achillion Pharmaceuticals (ACHN), Alnylam Pharmaceuticals (ALNY), GoPro (GPRO), Ambarella (AMBA), Alkermes (ALKS), Align Technology (ALGN), Akebia Therapeutics (AKBA), Agios Pharmaceuticals (AGIO), ACADIA Pharmaceuticals (ACAD) and Arbutus Biopharma (ABUS). This page (NASDAQ:ASPX) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingA letter is coming from the "Bureau of the Fiscal Service".Stansberry ResearchElon’s New Device is About to Shock the WorldInvestorPlaceMake this ONE trade on Tuesday at 2 p.m. EST!Monument Traders Alliance[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressHe Is Giving Away BitcoinCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding (ASPX) Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
